Documento de consenso de la Sociedad Española de Cirugía Torácica (SECT). Seguimiento a largo plazo de los pacientes operados de cáncer de pulmón.

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  Sharyn I. Katz,et al.  Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Bonjer,et al.  Endobronchial and surgical treatment of pulmonary carcinoid tumors: A systematic literature review. , 2019, Lung cancer.

[4]  E. Basch,et al.  Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  Michael Lock,et al.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial , 2019, The Lancet.

[6]  N. Reguart,et al.  SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018) , 2018, Clinical and Translational Oncology.

[7]  David R. Jones,et al.  More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study , 2018, Annals of surgery.

[8]  M. Oudkerk,et al.  PL02.05 Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial , 2018, Journal of Thoracic Oncology.

[9]  C. Letellier,et al.  Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients , 2017, Journal of the National Cancer Institute.

[10]  E. Carcereny,et al.  Transbronchial and transesophageal fine-needle aspiration using a single ultrasound bronchoscope in the diagnosis of locoregional recurrence of surgically-treated lung cancer , 2017, BMC Pulmonary Medicine.

[11]  S. Wildermuth,et al.  Ultralow dose CT for pulmonary nodule detection with chest x-ray equivalent dose – a prospective intra-individual comparative study , 2017, European Radiology.

[12]  E. Barreiro,et al.  Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer. , 2016, Archivos de bronconeumologia.

[13]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  J. Coebergh,et al.  Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  T. Sutedja,et al.  Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids , 2015, Thorax.

[16]  I. Yoshino,et al.  Comparison between endobronchial ultrasound-guided transbronchial needle aspiration and 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of postoperative nodal recurrence in patients with lung cancer. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  G. Stukenborg,et al.  Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality. , 2014, The Journal of thoracic and cardiovascular surgery.

[18]  David R. Jones,et al.  Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. , 2014, The Annals of thoracic surgery.

[19]  David R. Jones,et al.  Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. , 2014, The Annals of thoracic surgery.

[20]  Seok Jeong Lee,et al.  Image quality assessment of ultra low-dose chest CT using sinogram-affirmed iterative reconstruction , 2014, European Radiology.

[21]  J. Meyerhardt,et al.  Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  S. Keshavjee,et al.  How to follow up patients after curative resection of lung cancer. , 2013, Seminars in thoracic and cardiovascular surgery.

[23]  S. Murgu,et al.  Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[24]  D. Wigle,et al.  Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. , 2013, The Journal of thoracic and cardiovascular surgery.

[25]  A. Tangoku,et al.  18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients. , 2012, Interactive cardiovascular and thoracic surgery.

[26]  R. Demicheli,et al.  Recurrence Dynamics for Non–Small-Cell Lung Cancer: Effect of Surgery on the Development of Metastases , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  P. Lorigan,et al.  Survival Benefits from Follow-Up of Patients with Lung Cancer: A Systematic Review and Meta-Analysis , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  J. Goo,et al.  Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer. , 2011, The Annals of thoracic surgery.

[29]  S. Matsumoto,et al.  Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations. , 2011, European journal of radiology.

[30]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[31]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[32]  Eugene C Lin,et al.  Radiation risk from medical imaging. , 2010, Mayo Clinic proceedings.

[33]  E. Lee,et al.  A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients. , 2010, The Journal of thoracic and cardiovascular surgery.

[34]  S. Matsumoto,et al.  Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients. , 2010, European journal of radiology.

[35]  O. Israel,et al.  Patterns of FDG uptake in post-thoracotomy surgical scars in patients with lung cancer. , 2008, The British journal of radiology.

[36]  P. Pairolero,et al.  Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. , 2007, The Annals of thoracic surgery.

[37]  W. Alberts,et al.  Follow up and surveillance of the patient with lung cancer: What do you do after surgery? , 2007, Respirology.

[38]  Ora Israel,et al.  Cancer Recurrence: Diagnostic Value and Impact on Patient Management , 2004 .

[39]  L. Voltolini,et al.  Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[40]  A. Depierre,et al.  Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. , 2000, Annals of Thoracic Surgery.

[41]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[42]  M Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  N. Paul,et al.  Minimal-dose computed tomography is superior to chest x-ray for the follow-up and treatment of patients with resected lung cancer. , 2014, The Journal of thoracic and cardiovascular surgery.

[44]  C. Sima,et al.  Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. , 2013, The Journal of thoracic and cardiovascular surgery.

[45]  Ursula Nestle,et al.  Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.